This article is a theoretical analysis of various pharmaceutical systems in Europe, and try to draw conclusions about the advantages and disadvantages of each system. The mechanisms by which they are generated and allocated funds in European health systems are extremely complex and vary from...

In this paper we document a process of price convergence in the European market for pharmaceutical products and relate it to access to innovative medicines in individual countries. The EU is a peculiar case study, where free circulation of goods coexists with pricing policies designed and...

There is a strong political will in the Western Balkan states to align the region's pharmaceutical legislation and practice with that of the European Union. Accordingly, recent policy changes were aimed at harmonization of policies with other European countries. Several national drug laws were...